gmi logo.jpg
Pharmacovigilance Market 2021 | Emerging Trends & Global Forecast to 2027: Global Market Insights Inc.
October 19, 2021 05:00 ET | Global Market Insights, Inc
Selbyville, Delaware, Oct. 19, 2021 (GLOBE NEWSWIRE) -- The pharmacovigilance market size is anticipated to record a valuation of USD 12.9 billion by 2027, according to the most recent study by...
Logo.jpg
Celsion Reports T-cell and B-cell Response from In Vivo Studies with its PLACCINE DNA Vaccine Platform
September 02, 2021 08:00 ET | Celsion CORP
Results Indicate Induction of Adaptive Immune Response Against SARS-CoV-2 Company Plans Additional Development Work to Further Optimize its Vaccine Platform Through Vector Compositions, Delivery...
Adaptimmune logo Colour_white background_no strap.jpg
First Preclinical Data from Adaptimmune’s Mesothelin HiT Program at ASGCT Demonstrate Antigen-specific Tumor Cell Killing in vitro and Complete Tumor Regression in an Animal Model
May 11, 2021 08:00 ET | Adaptimmune Therapeutics plc
- Preclinical data validate that human T-cells expressing a TCR targeting mesothelin, independent of HLA recognition, can kill human tumor cells - - HiT works as well, or better than, a TRuC...
Adaptimmune logo Colour_white background_no strap.jpg
Adaptimmune to Present First Preclinical Data from its HLA-independent TCR (HiT) Platform at ASGCT
April 27, 2021 16:30 ET | Adaptimmune Therapeutics plc
PHILADELPHIA and OXFORDSHIRE, United Kingdom, April 27, 2021 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in cell therapy to treat cancer, will report initial preclinical...
Logo-uniQure-MS-Word_Orange.jpg
uniQure Announces Publications of Preclinical Data for AMT-130 in Huntington’s Disease Showing Safety of Administration in NHPs and Widespread Long-Term HTT-Lowering in the Brain
April 08, 2021 07:05 ET | uniQure Inc.
LEXINGTON, Mass. and AMSTERDAM, April 08, 2021 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical...
ARC logo.png
Preclinical CRO Market Value Anticipated To Reach US$ 8.2 Billion By 2027: Acumen Research And Consulting
March 09, 2021 12:27 ET | Acumen Research and Consulting
Acumen Research and Consulting, a global provider of market research studies, in a recently published report titled “Preclinical CRO Market – Global Industry Analysis, Market Size, Opportunities and...
Pfizer and BioNTech Publish Preclinical Data from Investigational COVID-19 Vaccine Program in Nature
February 01, 2021 08:32 ET | BioNTech SE
New York, NY and Mainz, Germany, February 1, 2021 (GLOBE NEWSWIRE) — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that preclinical data in non-human primate and mouse models...
Pfizer und BioNTech veröffentlichen präklinische Daten zu COVID-19-Impfstoffprogramm in Nature
February 01, 2021 08:32 ET | BioNTech SE
New York und Mainz, Deutschland, 1. Februar 2021 — Pfizer Inc (NYSE: PFE) und BionTech SE (Nasdaq: BNTX) gaben heute die Publikation präklinischer Ergebnisse zu ihren mRNA-basierten...
Logo_final_color.png
Cybrexa Therapeutics to Present First Efficacy and Safety Data From Its Lead Program CBX-12 and Initial Data From CBX-13 at the American Association for Cancer Research (AACR) Virtual Annual Meeting II
May 15, 2020 04:00 ET | Cybrexa Therapeutics
NEW HAVEN, Conn., May 15, 2020 (GLOBE NEWSWIRE) -- Cybrexa Therapeutics, an oncology-focused biotechnology company developing a new class of therapeutics through its alphalex™ tumor targeting...
Altasciences_Gradient_V_RGB.png
Altasciences完成Gimsilumab用于新冠肺炎(COVID-19)患者ARDS的一期研究
March 28, 2020 06:57 ET | Altasciences Company Inc.
魁北克拉瓦尔, March 28, 2020 (GLOBE NEWSWIRE) --...